Clinical Trial

Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction

Study acronym: UNLOAD-HFpEF
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Heart failure with preserved ejection fraction has a high mortality, which is contrasted by a total absence of therapy options besides symptomatic diuretic treatment. This study aims to explore the potential of renal denervation as a treatment option for heart failure with preserved ejection fraction.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05030987
Lead Sponsor University of Leipzig
Collaborators: ReCor Medical, Inc.
Conditions Heart Failure With Preserved Ejection Fraction, Hypertension, Renal
Enrollment 68 participants
Start Date 2021-11-30
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-17